Concepedia

Author

Manuela Benary

Charité - Universitätsmedizin BerlinORCID

Also Known As

Benary, Manuela, M Benary, M. Benary, MANUELA BENARY, Manuela Benary

32

Publications

730

Citations

11

H-Index

39

Concepts

All Affiliations

Charité - Universitätsmedizin BerlinHumboldt-Universität zu BerlinHeidelberg UniversityGerman Cancer Research CenterBerlin Institute of Health at Charité - Universitätsmedizin Berlin
MB

About

Manuela Benary is an author at Charité - Universitätsmedizin Berlin specializing in medicine, cancer research, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

271

2

Cell Biology

2

2

26

3

Pathology

2

2

245

4

Cellular Physiology

1

1

16

5

Immunology

1

1

10

Manuela Benary

×

12

Publications

691

Citations

11

H-Index

YearCitations

Leveraging Large Language Models for Decision Support in Personalized Oncology

Manuela Benary, Xing David Wang, Max Schmidt,

JAMA Network Open

2023

242

Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)

Peter Horak, Malachi Griffith, Arpad Danos,

Genetics in Medicine

2022

211

Comparative Analysis of Public Knowledge Bases for Precision Oncology

Steffen Pallarz, Manuela Benary, Mario Lamping,

JCO Precision Oncology

2019

67

Support of a molecular tumour board by an evidence-based decision management system for precision oncology

Mario Lamping, Manuela Benary, Serge Leyvraz,

European Journal of Cancer

2020

34

How cyanobacteria pose new problems to old methods: challenges in microarray time series analysis

Robert Lehmann, Rainer Machné, Jens Georg,

BMC Bioinformatics

2013

25

ESMO Precision Oncology Working Group recommendations on the structure and quality indicators for molecular tumour boards in clinical practice

C. Benedikt Westphalen, L. Boscolo Bielo, Philippe Aftimos,

Annals of Oncology

2025

25

Feasibility and outcome of reproducible clinical interpretation of high-dimensional molecular data: a comparison of two molecular tumor boards

Damian Rieke, Till de Bortoli, Peter Horak,

BMC Medicine

2022

21

The proteogenomic landscape of multiple myeloma reveals insights into disease biology and therapeutic opportunities

Evelyn Ramberger, Valeriia Sapozhnikova, Yuen Lam Dora Ng,

Nature Cancer

2024

18

Disentangling Pro-mitotic Signaling during Cell Cycle Progression using Time-Resolved Single-Cell Imaging

Manuela Benary, Stefan Bohn, Mareen Lüthen,

Cell Reports

2020

16

IL-2 Expression in Activated Human Memory FOXP3+ Cells Critically Depends on the Cellular Levels of FOXP3 as Well as of Four Transcription Factors of  T Cell Activation

Hanna Bendfeldt, Manuela Benary, Tobias Scheel,

Frontiers in Immunology

2012

11

Page 1